PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Karampelias, C. ; Yang, K. ; Farkas, F. ; Sterr, M. ; Molina van Den Bosch, M. ; Renner, S.* ; Fuß, J.* ; von Toerne, C. ; Franzenburg, S.* ; Kin, T.* ; Wolf, E.* ; Kemter, E.* ; Lickert, H.

Benchmarking porcine pancreatic ductal organoids for drug screening applications.

EMBO Mol. Med., DOI: 10.1038/s44321-025-00330-3 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Primary human pancreatic ductal organoids (HPDO) have emerged as a model to study pancreas biology and model disease like pancreatitis and pancreatic cancer. Yet, donor material availability, genetic variability and a lack of extensive benchmarking to healthy and disease pancreas limits the range of applications. To address this gap, we established porcine pancreatic ductal organoids (PPDO) as a system from a reliable, genetically defined and easily obtainable source to model pancreatic ductal/progenitor biology. We benchmarked PPDO to HPDO and primary porcine pancreas using single-cell RNA sequencing (scRNA-Seq). We observed no overt phenotypic differences in PPDO derived from distinct developmental stages using extensive proteomics profiling, with a WNT/basal cell signaling enriched population characterizing PPDO. PPDO exhibited differentiation potential towards mature ductal cells and limited potential towards endocrine lineages. We used PPDO as a chemical screening platform to assess the safety of FDA-approved drugs and showed conserved toxicity of statins and α-adrenergic receptor inhibitors between PPDO and HPDO cultures. Overall, our results highlight the PPDO as a model for mammalian duct/progenitor applications.
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Chemical Screen ; Cross-species Comparison ; Omics Profile ; Pancreatic Ductal Organoids ; Porcine Pancreas ; Proteome Profile ; Scrna-seq Profile; Beta-cells; Progenitor Cells; Mouse Pancreas; Stem-cells; In-vitro; Adult; Expansion; Differentiation; Establishment; Expression
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 1757-4676
e-ISSN 1757-4684
Zeitschrift EMBO Molecular Medicine
Verlag Wiley
Verlagsort Chichester
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Regeneration Research (IDR)
CF Metabolomics & Proteomics (CF-MPC)
POF Topic(s) 30201 - Metabolic Health
90000 - German Center for Diabetes Research
30203 - Molecular Targets and Therapies
Forschungsfeld(er) Helmholtz Diabetes Center
Enabling and Novel Technologies
PSP-Element(e) G-502300-001
G-501900-231
G-502301-001
G-505700-001
Förderungen
Deutsche Forschungsgemeinschaft (DFG)
Deutsches Zentrum fr Diabetesforschung (DZD)
Innovative Health Initiative NHPig
Helmholtz Society
Breakthrough Type 1 DIabetes
Helmholtz Research school for Diabetes funded by Helmholtz Association - Initiative and Networking Fund (IVF)
Alexander von Humboldt-Stiftung (AvH)
DOI 10.1038/s44321-025-00330-3
WOS ID 001607237900001
Scopus ID 105021258217
PubMed ID 41188536
Erfassungsdatum 2025-11-06
[➜Korrektur melden]